Victory Capital Management Inc. Has $68.21 Million Holdings in Integer Holdings Co. (NYSE:ITGR)

Victory Capital Management Inc. reduced its stake in shares of Integer Holdings Co. (NYSE:ITGR) by 18.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 514,693 shares of the medical equipment provider’s stock after selling 113,193 shares during the quarter. Victory Capital Management Inc. owned 1.53% of Integer worth $68,207,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Loomis Sayles & Co. L P raised its stake in shares of Integer by 3.0% in the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock valued at $69,943,000 after buying an additional 15,446 shares in the last quarter. Jane Street Group LLC raised its stake in shares of Integer by 23.3% in the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after buying an additional 28,572 shares in the last quarter. Verition Fund Management LLC raised its stake in shares of Integer by 17.4% in the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider’s stock valued at $451,000 after buying an additional 515 shares in the last quarter. Versant Capital Management Inc raised its stake in shares of Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after buying an additional 183 shares in the last quarter. Finally, KBC Group NV raised its stake in shares of Integer by 83.3% in the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider’s stock valued at $212,000 after buying an additional 726 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Stock Down 0.7 %

Shares of NYSE:ITGR opened at $121.84 on Friday. Integer Holdings Co. has a 12 month low of $107.11 and a 12 month high of $146.36. The company’s 50-day moving average price is $135.73 and its two-hundred day moving average price is $132.87. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The firm has a market cap of $4.10 billion, a P/E ratio of 36.26, a P/E/G ratio of 1.72 and a beta of 1.13.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The company had revenue of $449.50 million for the quarter, compared to the consensus estimate of $446.28 million. As a group, research analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ITGR. Truist Financial increased their price objective on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Benchmark upped their target price on shares of Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Friday, February 21st. Citigroup upped their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, December 11th. KeyCorp upped their target price on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and issued a $160.00 target price on shares of Integer in a report on Tuesday, December 3rd. Two equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $147.67.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.